Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07214259) titled 'Intervention for Alcohol Use Disorder Recovery After Liver Transplantation' on... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07214519) titled 'Permanent Supportive Housing Overdose Prevention-2 Study' on Sept. 24. Study ... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07214532) titled 'Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer' on Sept. 24. Stud... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07213531) titled 'Enhanced Valves Interventions and Safe AI Generated End Results' on Sept. 24. ... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07214038) titled 'A Clinical Study to Evaluate the Stain Reduction Efficacy of a Non-Fluoride To... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07214402) titled 'Mediterranean Dietary Intervention on ROS Levels and TAC During Pregnancy' on ... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07215650) titled 'Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)' on Sept. 2... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07215273) titled 'Study of EL219 vs Standard of Care for Early Antifungal Therapy of Suspected I... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07215637) titled 'Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Su... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07201389) titled 'CARE (Chemotherapy Alopecia REduction)' on Sept. 24. Study Type: Intervention... Read More